Italy Biopharmaceutical Company Chiesi Group Buys United States Biopharmaceutical Company KalVista Pharmaceuticals for $1.9 Billion in All-Cash Deal, Representing +36% Premium to 30-Day VWAP (28/4/26), KalVista Founded in 2011 by Robert Haigh, KalVista Pharmaceuticals Current Market Value at $1.4 Billion, Share Price +72.9% YTD, +113.9% Last 12 Months & +7.8% Last 5 Years

Caproasia.com | The leading source of data, research, information & resource for financial professionals, investment managers, professional investors, family offices & advisors to institutions, billionaires, UHNWs & HNWs. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets? Caproasia - Learn more

Caproasia Access | Events | Summits | Register Events | The Financial Centre
The 2026 Investment Day | 2026 Family Office Summits | Family Office Circle

This site is for accredited investors, professional investors, investment managers and financial professionals only. You should have assets around $3 million to $300 million or managing $20 million to $30 billion.

---

Italy Biopharmaceutical Company Chiesi Group Buys United States Biopharmaceutical Company KalVista Pharmaceuticals for $1.9 Billion in All-Cash Deal, Representing +36% Premium to 30-Day VWAP (28/4/26), KalVista Founded in 2011 by Robert Haigh, KalVista Pharmaceuticals Current Market Value at $1.4 Billion, Share Price +72.9% YTD, +113.9% Last 12 Months & +7.8% Last 5 Years

6th May 2026 | Hong Kong

Italy biopharmaceutical company Chiesi Group has announced to buy United States biopharmaceutical company KalVista Pharmaceuticals ($1.4 billion market value) for $1.9 billion in all-cash deal, representing +36% premium to KalVista 30-day volume-weighted average share price (30/4/26).  KalVista Pharmaceuticals was founded in 2011 by Robert Haigh.  KalVista Pharmaceuticals current market value at $1.4 billion, share price +65.4% YTD, +113.9% last 12 months & +7.8% last 5 years. KalVista Pharmaceuticals – KalVista is a global pharmaceutical company dedicated to delivering life-changing oral therapies for individuals affected by rare diseases with significant unmet needs. The KalVista team discovered and developed sebetralstat—the first oral on-demand treatment for hereditary angioedema (HAE)—and continues to work closely with the global HAE community to improve treatment and care for this disease around the world. Chiesi Group – Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment.  Chiesi Group – Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status in Benefit Corporation in Italy, the US, France and Colombia, Chiesi’s commitment to creating shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, Chiesi is part of a global community of businesses that meet verified standards of social and environmental impact. The company aims to reach Net-Zero greenhouse gases (GHG) emissions by 2035.  With 90 years of experience, Chiesi is headquartered in Parma (Italy), with 31 affiliates worldwide, and counts more than 7,900 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden.

“ Italy Biopharmaceutical Company Chiesi Group Buys United States Biopharmaceutical Company KalVista Pharmaceuticals for $1.9 Billion in All-Cash Deal, Representing +36% Premium to 30-Day VWAP (28/4/26), KalVista Founded in 2011 by Robert Haigh, KalVista Pharmaceuticals Current Market Value at $1.4 Billion, Share Price +72.9% YTD, +113.9% Last 12 Months & +7.8% Last 5 Years “

- Article continues below -

Quick Links, Ads & Announcements
Caproasia Access | Events | Summits | Register Events | The Financial Centre
The 2026 Investment Day | 2026 Family Office Summits | Family Office Circle

Intelligence at your fingertips
Get Started ($29 per year) : Click here
Caproasia Subscription ($680 yearly | $70 monthly): Click here

The 2026 Investment Day
Hong Kong | Singapore
March / July / Sept / Oct / Nov
Private Equity, Hedge Funds, Boutique Funds, Private Markets & more. Join 20+ CIOs & Senior investment team, with > 60% single family offices with $300 million AUM. Taking place in Hong Kong and in Singapore. Every March, April, July, Sept, Oct & Nov.
Visit | Register here

The 2026 Family Office Summit
9th / 16th April & 15th Oct Hong Kong Ritz Carlton | 23rd / 30th April & 5th Nov Singapore Amara Sanctuary Resort
Join 60 single family offices & family office professionals in Hong Kong & Singapore
Links: 2026 Family Office Summit | Register here

2026 Investment / Alternatives Summit
March / Oct / Nov in Hong Kong & Singapore
Join leading asset managers, hedge funds, boutique funds, private equity, venture capital & real estate firms in Hong Kong, Singapore & Asia-Pacific at the Investment / Alternatives Summit. Join as delegate, speaker, presenter, partner & sponsor.
Visit | Register here

2026 Private Wealth Summit
April / Oct / Nov in Hong Kong & Singapore
Join CEOs, CIOs, Head of Private Banking, Head of Family Offices & Product Heads at The Private Wealth Summit.  Join as delegate, speaker, presenter, partner & sponsor.
Visit | Register here

Italy Biopharmaceutical Company Chiesi Group Buys United States Biopharmaceutical Company KalVista Pharmaceuticals for $1.9 Billion in All-Cash Deal, Representing +36% Premium to 30-Day VWAP (28/4/26), KalVista Founded in 2011 by Robert Haigh, KalVista Pharmaceuticals Current Market Value at $1.4 Billion, Share Price +72.9% YTD, +113.9% Last 12 Months & +7.8% Last 5 Years

Managing $20 million to $3 billion. Investing $3 million to $300 million.
For Investment Managers, Hedge Funds, Boutique Funds, Private Equity, Venture Capital, Professional Investors, Family Offices, Private Bankers & Advisors, sign up today. Subscribe to Caproasia and receive the latest news, data, insights & reports, events & programs daily at 2 pm.

Join Events & Find Services
Join Investments, Private Wealth, Family Office events in Hong Kong, Singapore, Asia-wide. Find hard-to-find $3 million to $300 million financial & investment services at The Financial Centre | TFC. Find financial, investment, private wealth, family office, real estate, luxury investments, citizenship, law firms & more.  List hard-to-find financial & private wealth services.

Have a product launch? Promote a product or service? List your service at The Financial Centre | TFC. Join interviews & editorial and be featured on Caproasia.com or join Investments, Private Wealth, Family Office events. Contact us at [email protected] or [email protected]

Caproasia.com | The leading source of data, research, information & resource for financial professionals, investment managers, professional investors, family offices & advisors to institutions, billionaires, UHNWs & HNWs. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets?

Quick Links

Caproasia Access | Events | Summits | Register Events | The Financial Centre
The 2026 Investment Day | 2026 Family Office Summits | Family Office Circle

Web links may be disabled on mobile for security.
Please click on desktop.

---

New to Caproasia
Learn More | Sign Up | Subscribe | Register Events

Caproasia Users

• Manage $20 million to $30 billion of assets
• Invest $3 million to $300 million
• Advise institutions, billionaires, UHNWs & HNWs

Caproasia Platforms | 11,000 Investors & Advisors

• Caproasia.com
• Caproasia Access
• Caproasia Events
• The Financial Centre | Find Services
• Membership
• Family Office Circle
• Professional Investor Circle
• Investor Relations Network

Monthly Roundtable & Networking

• Professional Investor
• Family Office
• HNW Partnership

Family Office Programs

• Family Office Circle
• Family Office Networking
• Family Office Roundtable
• The Family Office Summit

The 2026 Investment Day

• March - Hong Kong
• March - Singapore
• April - Hong Kong
• April - Singapore
• July - Hong Kong
• July - Singapore
• Sept- Hong Kong
• Sept - Singapore
• Oct- Hong Kong
• Nov - Singapore
• Visit: The Investment Day | Register: Click here

Caproasia Summits

• The Institutional Investor Summit
• The Investment / Alternatives Summit
• The Private Wealth Summit
• The Family Office Summit
• The CEO & Entrepreneur Summit
• The Capital Markets Summit
• The ESG / Sustainable Investment Summit

Contact Us

For Enquiries, Membership
[email protected], [email protected]

For Listing, Subscription
[email protected], [email protected]

For Press Release, send to:
[email protected]

For Events & Webinars
[email protected]

For Media Kit, Advertising, Sponsorships, Partnerships
[email protected]

For Research, Data, Surveys, Reports
[email protected]

For General Enquiries
[email protected]

---

Caproasia | Driving the future of Asia
a financial information technology co.
since 2014

---